{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:09:21Z","timestamp":1761487761747},"reference-count":27,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2007.01.021","type":"journal-article","created":{"date-parts":[[2007,1,19]],"date-time":"2007-01-19T12:19:09Z","timestamp":1169209149000},"page":"3085-3089","source":"Crossref","is-referenced-by-count":28,"title":["Prevenar\u2122 vaccination: Review of the global data, 2006"],"prefix":"10.1016","volume":"25","author":[{"given":"Kimberly J.","family":"Center","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.vaccine.2007.01.021_bib1","first-page":"511","article-title":"Vaccine preventable deaths and the global immunization vision and strategy, 2006\u20132015","volume":"55","author":"CDC","year":"2006","journal-title":"Morbid Mortal Weekly Rep"},{"key":"10.1016\/j.vaccine.2007.01.021_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-9","key":"10.1016\/j.vaccine.2007.01.021_bib3","first-page":"1","article-title":"Preventing pneumococcal disease among infants and young children: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"49","author":"CDC","year":"2000","journal-title":"Morbid Mortal Weekly Rep"},{"key":"10.1016\/j.vaccine.2007.01.021_bib4","unstructured":"CDC. Active bacterial core surveillance report\u2014Streptococcus pneumoniae, 1999. Available at: http:\/\/www.cdc.gov\/ncidod\/dbmd\/abcs\/survreports.htm."},{"issue":"3","key":"10.1016\/j.vaccine.2007.01.021_bib5","doi-asserted-by":"crossref","first-page":"e801","DOI":"10.1542\/peds.2005-3195","article-title":"Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough","volume":"118","author":"Vergison","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2007.01.021_bib6","first-page":"1","article-title":"Burden of paediatric invasive pneumococcal disease in Europe, 2005","author":"McIntosh","year":"2006","journal-title":"Epidemiol Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2007.01.021_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.inf.0000208368.67448.51","article-title":"Active epidemiologic surveillance of pneumonia and invasive pneumococcal disease in ambulatory and hospitalized infants in Cordoba, Argentina","volume":"25","author":"Tregnaghi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2007.01.021_bib8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S1020-49892006000500007","article-title":"Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction","volume":"19","author":"Garcia","year":"2006","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2007.01.021_bib9","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3201\/eid1007.030612","article-title":"Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995\u20132001","volume":"10","author":"Ho","year":"2004","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.vaccine.2007.01.021_bib10","series-title":"Presented at the 43rd Annual Meeting of the Infectious Diseases Society of America","article-title":"Serotypes and antibiotic susceptibility of invasive pneumococcal isolates in Asia","author":"Kennedy","year":"2005"},{"issue":"36","key":"10.1016\/j.vaccine.2007.01.021_bib11","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003","volume":"54","author":"CDC","year":"2005","journal-title":"Morbid Mortal Weekly Rep"},{"key":"10.1016\/j.vaccine.2007.01.021_bib12","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.01.021_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-144-1-200601030-00004","article-title":"Changes in invasive pneumococcal disease among HIV-infected adults living the era of childhood pneumococcal immunization","volume":"144","author":"Flannery","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2007.01.021_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/01.inf.0000133046.60555.de","article-title":"Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine","volume":"23","author":"Talbot","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"ACS-2","key":"10.1016\/j.vaccine.2007.01.021_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v38i00a02a","article-title":"Statement on recommended use of pneumococcal conjugate vaccine","volume":"28","author":"National Advisory Committee on Immunization (NACI)","year":"2002","journal-title":"Can Commun Dis Rep"},{"issue":"ACS-4","key":"10.1016\/j.vaccine.2007.01.021_bib16","first-page":"1","article-title":"Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants","volume":"32","author":"National Advisory Committee on Immunization (NACI)","year":"2006","journal-title":"Can Commun Dis Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2007.01.021_bib17","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1503\/cmaj.051150","article-title":"Progress in the prevention of pneumococcal infection","volume":"173","author":"Kellner","year":"2005","journal-title":"CMAJ"},{"issue":"14","key":"10.1016\/j.vaccine.2007.01.021_bib18","first-page":"157","article-title":"Incidence of invasive pneumococcal disease after introduction of the universal infant immunization program, British Columbia (2002\u20132005)","volume":"32","author":"Paulus","year":"2006","journal-title":"Can Commun Dis Rep"},{"issue":"16","key":"10.1016\/j.vaccine.2007.01.021_bib19","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.01.021_bib20","doi-asserted-by":"crossref","unstructured":"de Aristegui Fernandez J, Bernaola Iturbe E, Pocheville I, Garc\u00eda Calvo C, Arranz L, Dur\u00e1n G, et al. Reduction of pediatric invasive pneumococcal disease in the Basque Country and Navarre after the introduction of the heptavalent pneumococcal conjugate vaccine. Basque Country\/Navarre Invasive Pneumococcal Disease Study Group. Eur J Clin Microbiol Infect Dis 2007, in press.","DOI":"10.1007\/s10096-007-0294-4"},{"key":"10.1016\/j.vaccine.2007.01.021_bib21","unstructured":"Reseau Epibac (surveillance des infections invasives \u00e0 Haemophilus influenzae, \u2026). Donn\u00e9es \u00e9pid\u00e9miologiques 2005 (25 Octobre 2006). URL: http:\/\/www.invs.sante.fr\/surveillance\/epibac\/publications.htm. Accessed 19 January 2006."},{"issue":"1","key":"10.1016\/j.vaccine.2007.01.021_bib22","first-page":"80","article-title":"Invasive pneumococcal disease in Australia, 2004","volume":"30","author":"Roche","year":"2006","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2007.01.021_bib23","series-title":"Presented at the Pediatric Academic Societies\u2019 2006 Annual Meeting","article-title":"Postmarketing assessment of Prevnar\u00ae, 7-valent pneumococcal conjugate vaccine (PNCV7)","author":"Black","year":"2006"},{"key":"10.1016\/j.vaccine.2007.01.021_bib24","series-title":"Presented at the 44th Annual Meeting of the Infectious Diseases Society of America","article-title":"Postmarketing assessment of uncommon events following Prevnar\u00ae, 7-valent pneumococcal conjugate vaccine","author":"Black","year":"2006"},{"issue":"14","key":"10.1016\/j.vaccine.2007.01.021_bib25","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.292.14.1702","article-title":"Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine","volume":"292","author":"Wise","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.01.021_bib26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.283.11.1460","article-title":"Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children","volume":"283","author":"Lieu","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2007.01.021_bib27","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.inf.0000222403.42974.8b","article-title":"Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects","volume":"25","author":"Ray","year":"2006","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T20:23:44Z","timestamp":1587327824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":27,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X07000461"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}